Skip to main content

QUETIAPINE FUMARATE

NDC 16729-095 · Accord Healthcare Inc.

Generic nameQUETIAPINE FUMARATE
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)QUETIAPINE FUMARATE
Strength200 mg/1
Pharmacologic classAtypical Antipsychotic [EPC]
Marketing categoryANDA

Packages

16729-095-12 — 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-095-12)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

16571-720 — Quetiapine Fumarate, 16571-721 — Quetiapine Fumarate, 16571-722 — Quetiapine Fumarate, 16571-809 — Quetiapine Fumarate, 16714-375 — Quetiapine Fumarate, 16714-376 — Quetiapine Fumarate, 16714-377 — Quetiapine Fumarate, 16714-378 — Quetiapine Fumarate, 16714-379 — Quetiapine Fumarate, 16714-380 — Quetiapine Fumarate, 16729-096 — QUETIAPINE FUMARATE, 16729-097 — QUETIAPINE FUMARATE, 16729-109 — QUETIAPINE FUMARATE, 16729-132 — QUETIAPINE FUMARATE, 16729-145 — Quetiapine, 16729-146 — Quetiapine, 16729-147 — Quetiapine, 16729-148 — Quetiapine, 16729-149 — Quetiapine, 16729-150 — Quetiapine, +323 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels